Growth Metrics

Cytosorbents (CTSO) Gross Profit Growth (3y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 5.02%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 8.10%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 4.54%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 15.44%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 9.03%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.15%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 17.49%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 1.49%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 8.46%
10 Cytosorbents 28.81 Mn 24.01 Mn 6.13 Mn 3.96%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.96%
Dec 31, 2025 5.73%
Sep 30, 2025 22.60%
Jun 30, 2025 11.28%
Mar 31, 2025 -1.09%
Dec 31, 2024 -6.53%
Sep 30, 2024 -10.36%
Jun 30, 2024 -11.29%
Mar 31, 2024 -4.32%
Dec 31, 2023 -17.41%
Sep 30, 2023 -9.86%
Jun 30, 2023 -2.76%
Mar 31, 2023 -4.80%
Dec 31, 2022 2.57%
Sep 30, 2022 -6.31%
Jun 30, 2022 3.98%
Mar 31, 2022 22.92%
Dec 31, 2021 24.20%
Sep 30, 2021 25.52%
Jun 30, 2021 32.88%
Mar 31, 2021 32.72%
Dec 31, 2020 40.75%
Sep 30, 2020 49.15%
Jun 30, 2020 46.44%
Mar 31, 2020 50.38%
Dec 31, 2019 44.01%
Sep 30, 2019 44.83%
Jun 30, 2019 48.28%
Mar 31, 2019 51.62%
Dec 31, 2018 61.04%
Sep 30, 2018 73.65%
Jun 30, 2018 99.69%
Mar 31, 2018 100.16%
Dec 31, 2017 83.83%
Sep 30, 2017 49.80%
Jun 30, 2017 79.81%
Mar 31, 2017 66.93%
Dec 31, 2016 251.08%
Sep 30, 2016 77.23%
Jun 30, 2016 144.83%
Mar 31, 2016 103.35%
Dec 31, 2015 20.57%
Sep 30, 2015 14.99%
Jun 30, 2015 89.75%
Mar 31, 2015 390.24%
Dec 31, 2014 181.83%